VeriMomceteareth-25 hamilelikte güvenli mi?
No harmonised reproductive classification on ECHA for ceteareth‑25 and the Cosmetic Ingredient Review (CIR) panel concluded alkyl‑PEG (ceteareth) ethers are safe as used when formulated to be non‑irritating; no peer‑reviewed evidence of reproductive or developmental toxicity specific to ceteareth‑25 was found. Dermal absorption is possible but low for high‑MW PEG‑ether fatty alcohols, so exposure from topical cosmetic use is low but measurable. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/23064774/?utm_source=openai))
Pregnancy-safe products containing ceteareth-25
Related ingredients
Frequently asked questions
- ceteareth-25 hamilelikte güvenli mi?
- No harmonised reproductive classification on ECHA for ceteareth‑25 and the Cosmetic Ingredient Review (CIR) panel concluded alkyl‑PEG (ceteareth) ethers are safe as used when formulated to be non‑irritating; no peer‑reviewed evidence of reproductive or developmental toxicity specific to ceteareth‑25 was found. Dermal absorption is possible but low for high‑MW PEG‑ether fatty alcohols, so exposure from topical cosmetic use is low but measurable. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/23064774/?utm_source=openai))
- ceteareth-25 emzirirken güvenli mi?
- Same weight‑of‑evidence as for pregnancy: no data showing reproductive or lactational toxicity, CIR conclusion of 'safe as used', and absence of harmonised CLP reproductive hazard; dermal use implies low but measurable maternal systemic exposure and therefore low potential for transfer via breastmilk. Main concern would be impurities (ethylene oxide/1,4‑dioxane) rather than the Ceteareth molecule itself. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/23064774/?utm_source=openai))
- ceteareth-25 bebek cildi için güvenli mi?
- No infant‑specific studies showing reproductive or developmental hazard or mechanism. Per instruction, because adult dermal exposure is low but measurable (e=1), infant exposure is increased by +1 due to immature skin barrier/higher surface‑area‑to‑weight, yielding e=2. CIR/Safety review did not identify Ceteareth‑25 as a developmental/reproductive hazard; primary practical concern for infants is irritation or impurity contamination, not intrinsic teratogenicity. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/23064774/?utm_source=openai))
- VeriMom ceteareth-25 nasıl puanlıyor?
- VeriMom ceteareth-25'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 93/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte ceteareth-25 yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.